SCOTUS Unanimously Raises Bar for Generic-Drug Induced Infringement ClaimsJune 9, 2026Legal NewsThe Supreme Court unanimously held that induced patent infringement claims require specific, affirmative acts of encouragement, protecting the generic-drug skinny-label pathway.
Supreme Court Unanimously Shields Generic Drug Skinny Labels From Infringement ClaimsJune 9, 2026Legal NewsThe Supreme Court unanimously ruled that Amarin Pharma failed to state a viable induced-infringement claim against Hikma's skinny-label generic Vascepa, raising the pleading bar for brand drugmakers.
Sun Pharmaceutical, Taro Settle Generic Drug Price-Fixing MDL for $200 MillionMay 14, 2026Law and PolicySun Pharmaceutical and Taro Pharmaceutical agree to pay $200 million to settle generic drug price-fixing claims in the Eastern District of Pennsylvania MDL.